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Unlike systemic infections, little is known about the role of repeated localized infections 
on (re)shaping pathogen-specific memory CD8 T cell responses. Here, we used primary 
(1°) and secondary (2°) intranasal influenza virus infections of mice as a model to study 
intrinsic memory CD8 T cell properties. We show that secondary antigen exposure, rela-
tive to a single infection, generates memory CD8 T cell responses of superior magnitude 
in multiple tissue compartments including blood, spleen, draining lymph nodes, and 
lung. Unexpectedly, regardless of the significantly higher number of 2° memory CD8 
T cells, similar degree of protection against pulmonary challenge was observed in both 
groups of mice containing 1° or 2° memory CD8 T cells. Mechanistically, using pertussis 
toxin-induced migration block, we showed that superior antigen-driven proliferation and 
ability to relocate to the site of infection allowed 1° memory CD8 T cells to accumulate 
in the infected lung during the first few days after challenge, compensating for the ini-
tially lower cell numbers. Taken together, the history of antigen exposures to localized 
pulmonary infections, through altering basic cell biology, dictates dynamic properties of 
protective memory CD8 T cell responses. This knowledge has important implications for 
a design of novel and an improvement of existing vaccines and immunization strategies.
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inTrODUcTiOn
CD8 T cells play a crucial role in protection against numerous systemic and localized infections (1–6). 
Therefore, understanding the formation and maintenance of memory CD8 T cell pool, together with 
the shaping of its basic biological properties, is crucial for the development of better immunization 
strategies to combat infectious diseases.
The importance of understanding how antigen (pathogen) stimulation history impacts properties 
of memory CD8 T cell pool has been emphasized recently (7–9). Importantly, it has been shown that 
multiple antigen exposures to systemic infection dramatically change the gene expression profile of 
memory CD8 T cells, thus reshaping their phenotypic and functional properties (8). Furthermore, 
it has been shown, using a LCMV systemic infection model, that antigen exposure history defines 
the protective capacity of memory CD8 T cells, by determining specific cell intrinsic factors (10).
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Unlike systemic infections, the basic understanding of biol-
ogy of memory CD8 T cells induced upon localized infections 
is limited to a single-exposure model or early time after chal-
lenge (secondary) infection (4, 11–14). For example, a study 
focusing on comparison between primary effector and memory 
CD8 T cells induced after influenza infection revealed similar 
relative cytotoxic potential between these different cell types 
(15). On the other hand, whether and how functional proper-
ties of memory CD8 T cells induced by localized (influenza) 
infections are altered by multiple exposures to cognate antigen 
is not known. As numerous localized infections, such as pulmo-
nary virus infections (influenza, RSV, adenovirus, etc.), display 
either a seasonal or reoccurring nature (16, 17), study of CD8 T 
cell responses induced by such infections in the context of mul-
tiple antigen encounters is highly important. Addressing these 
major knowledge gaps could provide valuable information 
required for rational design of vaccines and/or immunization 
procedures.
Here, we used primary (1°) and secondary (2°) influenza A 
virus (IAV) infection of mice as a model to study the fundamental 
characteristics of memory CD8 T cells generated during local-
ized pulmonary infection. The study showed that, similarly to 
systemic infections, history of exposure to localized infections 
imprints changes in the numerical, phenotypic, and functional 
properties of the memory CD8 T cell pool. Importantly, some 
of these intrinsic properties, such as proliferation capacity and 
the ability to relocate to the site of infection, dictate the cellular 
dynamics and localization, thus determining the protection 
against subsequent pulmonary challenge.
MaTerials anD MeThODs
ethics statement
Female C57Bl/6 mice, 6–8 weeks old, were purchased from the 
National Cancer Institute (Fredericksburg, MD, USA). The study 
protocol was approved by University of Iowa Animal Care and 
Use committee. The animals were treated and handled in accord-
ance with guidelines established by the  committee.
influenza strains and generation of 
Memory cD8 T cells
All IAV infections were performed while mice were under the 
influence of ketamine/xylazine anesthesia. Virus inoculum was 
intranasally (IN) delivered in PBS in a final volume of 50 µl.
Secondary memory (2°M) CD8 T cell responses were gener-
ated in C57/Bl6 mice in two steps. First, mice were IN infected 
with 7 × 103 TCID50 (median tissue culture infective dose) of A/
H3N2/X31. Seventy days later (D0), mice were exposed to sec-
ondary IN infection with 104 TCID50 of A/H1N1/S12a (SEQ12) 
(PR8 escape mutant). The S12a mutant virus contains 12 amino 
acid substitutions in the globular domain of hemagglutinin (HA). 
It was derived from PR8 virus through 12 sequential selection 
steps in the presence of anti-HA monoclonal antibodies. This 
approach allowed for generation of HA drifted virus strain, with 
no effect on other antigenic determinants (18). Alignment of 
sequences derived from S13 mutant virus (a descendant of S12a) 
and wt PR8 showed absence of variation in sequences encoding 
nucleoprotein (NP) and polymerase acidic (PA) proteins bearing 
target CD8 T cell epitopes (18).
Primary memory (1°M) CD8 T cell responses were generated 
on D0 by IN infection with X31 virus. 1°M and 2°M CD8 T 
cells were analyzed 70–90  days postinfection. For the purpose 
of longitudinal analysis of the NP366-specific response, blood 
was obtained on days 10, 50, and 100 postinfection and analysis 
performed as previously described (8, 9).
Pulmonary challenge and lung Virus 
Titers
Protection against pulmonary virus infection was assessed 
70–90 days post-last IAV exposure. For this purpose, 1°M and 
2°M mice were exposed to IN challenge with 107 or 108 PFU of 
recombinant vaccinia virus (Vac) expressing full-length influenza 
NP (Vac-NP) or mock infected with Vac-OVA (both viruses are 
obtained from Dr. Jack Bennink, Laboratory of Viral Diseases, 
National Institute of Allergy and Infectious Diseases). Lungs were 
harvested 3 days post-challenge, homogenized, frozen, and kept 
at −80°C until used for titration. For determining Vac virus titers, 
BSC-40 cells were infected with 10× dilutions of lung supernatant 
in Iscove’s DMEM medium supplemented with 50  µg/ml gen-
tamicin, 100 U/ml penicillin, and 100 µg/ml streptomycin. Cells 
were incubated with the lung virus samples for 1 h at 37°C, with 
occasional rocking and afterward overlaid with complete DMEM. 
After in total 48 h incubation at 37°C, medium was aspirated, cells 
were fixed with 7% formaldehyde and stained with 0.5% crystal 
violet in 10% methanol, and plaques were counted (10, 19, 20).
intravascular exclusion and Preparation  
of lung samples
To distinguish cells in the lung vasculature from those imbed-
ded in the lung parenchyma, 3 min prior to sacrifice mice were 
intravenous (IVS) injected with 2  µg of anti-CD45.2 antibody 
(clone 104, BioLegend, San Diego, CA, USA) in PBS (21). 
Harvested lung was cut into small pieces and incubated for 1 h 
at 37°C in digestion medium composed of 125 U/ml collagenase 
and 0.1  mg/ml DNAse. After incubation, tissue was processed 
into single-cell suspension using cell strainers and leukocytes 
enriched by centrifugation in 35% Percoll in HBSS. Red blood 
cells were lysed using Vitalyze.
Tetramer staining and antibodies
Antigen-specific CD8 T cells were identified by labeling with 
Db/NP366 or Db/PA224 in house prepared tetramers for 1 h at 4°C 
(22). Tetramer staining was followed by surface staining with 
appropriate antibody cocktails for 20 min at 4°C. Surface mark-
ers were stained using following antibodies: anti-CD8 (clone 
53-6.7, BioLegend), anti-CD90.2 (clone 30-H12, BioLegend), 
anti-CD45.2 (clone 104, BioLegend), anti-CD103 (clone 2E7, 
BioLegend), anti-CD69 (clone H.12F3, BioLegend), anti-KLRG-1 
(clone 2F1, eBioscience, San Diego, CA, USA), anti-CD127 (clone 
A7R34, BioLegend), anti-CX3CR1 (clone SA011F11, BioLegend), 
anti-CXCR3 (clone CXCR3-173, BioLegend), and anti-CD49a 
(clone Ha31/8, BD Pharmingen). Intracellular cytokine staining 
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was performed using anti-IFNγ (clone XMG1.2, BioLegend), 
anti-TNF (clone MP6-XT22, BioLegend), and anti-IL2 (clone 
JES6-5H4, BioLegend) antibodies. Proliferation of CD8 T cells 
was assessed by intracellular staining with anti-Ki67 (clone 
MOPC-21, BD Pharmingen). Flow cytometry data were acquired 
using LSRFortessa (Becton Dickinson, Rutherford, NY, USA) and 
analyzed using the FlowJo software (Tree Star Inc., Ashland, OR, 
USA).
resUlTs
experimental Model
The major aim of this study is to investigate the influence 
of repeated localized pulmonary infections on shaping the 
pathogen-specific memory CD8 T cell compartment. For this 
purpose, we took advantage of a well-established mouse model 
of IAV infections (23–25) and generated virus-specific 1°M and 
2°M CD8 T cells by exposing naive wt C57Bl/6 mice to one or two 
intranasal IAV infections, respectively. The selected virus strains 
(H3N2 X31 and H1N1 S12a) share some common gene segments 
that encode virus core proteins (e.g., NP and PA protein) and 
thus CD8 T cells epitopes (NP366 and PA224), enabling successful 
boosting or primary memory CD8 T cell response by secondary 
infection (26, 27). This approach allowed us to study and compare 
the development of endogenous 1°M and 2°M CD8 T responses 
in an intact, wt host.
To be able to collect samples and perform analysis of both 1°M 
and 2°M CD8 T cells at the same time and this way minimize 
the variability between assays, we adopted the infection scheme 
depicted in the Figure 1A. Namely, 2°M CD8 T cell responses 
were generated in two steps: primary infection with H3N2 X31 
followed 70 days later by secondary infection with H1N1 S12a. At 
the same time of secondary infection, 1°M CD8 T cell responses 
were generated in a separate group of mice by exposure to H3N2 
X31. Mice harboring 1°M or 2°M CD8 T cell responses were 
sacrificed in groups of 4–5 mice on days 70–90 after the last 
infection, and analyses were performed. Longitudinal analysis 
of NP366-specific response was performed in a separate group of 
mice, and blood for this purpose was collected at days 10, 50, 
and 100.
secondary localized infection induces 
cD8 T cell responses of superior 
Magnitude
To study how repeated exposures to localized pulmonary infec-
tion influence the magnitude of memory CD8 T cell response, 
we focused our analysis on 1°M and 2°M CD8 T cell responses 
specific for two major epitopes: NP366 (Figures  1B–H) and 
PA224 (Figure S1 in Supplementary Material). Antigen-specific 
CD8 T cells were enumerated using MHC-I tetramer staining. 
Longitudinal analysis of the NP366-specific response in blood 
shows that secondary localized infection generates CD8 T cell 
responses that are of superior magnitude (~10× higher) com-
pared to 1°M responses. Importantly, these numerical differences 
are conserved throughout the memory phase (D50 and D100) 
(Figure 1B).
Snapshot analysis of NP366-specific CD8 T cell responses 
performed 70–90  days after the last infection in multiple tis-
sues confirmed our observation from the blood compartment 
(Figure  1C). In both spleen and draining mediastinal lymph 
nodes, 2°M NP366-specific responses exceeded 1°M responses 
by ~8× fold (Figures 1D,E). Similar results were observed with 
PA224-specific 1°M and 2°M CD8 T cell responses (Figures S1A–C 
in Supplementary Material).
Although antigen-specific CD8 T cell numbers measured 
in blood and lymphoid compartment can be used as a general 
assessment of the magnitude of virus-specific CD8 T cell 
response, characterization of the response in the lung, the target 
organ of respiratory pathogens, is essential. Furthermore, a major 
focus has recently been put on the population of tissue resident 
memory CD8 T cells (Trm) as the important mediators of protec-
tion against localized infections (6, 28, 29). As lung perfusion has 
shown to be inefficient in removing all the cells trapped in the lung 
vasculature and has the capacity to destroy lung parenchyma, we 
administered an intravascular (IV) CD45.2 stain to discriminate 
between CD8 T cells imbedded in the tissue parenchyma (IV−) 
from those in the capillaries (IV+) (Figure 1F) (30, 31). Results 
of NP366 tetramer staining of lung cells clearly show a large dif-
ference in magnitude of 1°M and 2°M CD8 T cell responses in 
both the IV+ and IV− lung compartment. Relative abundance of 
NP366-specific CD8 T cells, presented in Figure 1F as % of total 
IV+ or IV− CD8 T cells, was uniformly higher in lungs of mice 
exposed to two sequential infections compared to the lungs of 
mice exposed to a single infection. The difference in absolute 
numbers of NP366-specific 1°M and 2°M CD8 T cells (Figure 1G) 
was 14× and 5.6× in the lung parenchyma and the vasculature, 
respectively. Finally, enumeration of the NP366-specific IV− CD8 T 
cells expressing a conventional Trm phenotype (CD69+CD103+) 
(32, 33) shows that secondary exposure causes >10× increase in 
size of Trm population, relative to a single exposure (Figure 1H). 
A similar pattern was observed with PA224-specific CD8 T cells 
(Figures S1D–F in Supplementary Material).
In summary, the data show that the size of antigen-specific 
2°M CD8 T cell compartment dramatically exceeds the size of 
1°M compartment at all time points after infection. Although 
somewhat enhanced in the lung parenchyma, this trend is well 
preserved, in all the analyzed tissues. Given the notion that the 
CD8 T cell-dependent protection against a pathogen infection 
is mainly determined by the magnitude of the response (34, 35), 
our results suggest that higher-magnitude responses induced by 
secondary infection could provide superior protection against 
subsequent exposure to a pathogen expressing cognate antigen.
1°M and 2°M cD8 T cell responses show 
a similar level of control of Pulmonary 
Virus infection
Next, we determined whether the substantial increase in 
numbers of antigen-specific memory CD8 T cells is associated 
with superior protection of the lung against localized challenge. 
In order to determine CD8 T cell-mediated protection and 
avoid the contribution of non-CD8 T cell protective responses 
potentially induced by previous infections (36–38), we exposed 
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FigUre 1 | secondary infection induces memory cD8 T cell responses of a superior magnitude compared to a primary infection. (a) Naive C57Bl/6 
mice were exposed to a single IN infection with X31 H3N2 influenza A virus (IAV) (1°M). Alternatively, mice were infected with X31 H3N2 and 70 days later exposed 
to a secondary infection with S12a H1N1 IAV (2°M). From 70 to 90 days after the last IAV infection, groups of mice were sacrificed, organs were harvested, and 
analysis of memory CD8 T cell responses was performed. (B) Kinetic of NP366-specific CD8 T cell response followed using tetramer staining in blood of 1°M and 
2°M CD8 T cell-bearing mice (n = 15 mice/time point). Representative of two independent experiments. Error bars represent mean ± SEM. Unpaired t test; 
****p < 0.0001. (c–e) Snap shot analysis of NP366-specific CD8 T cell response measured in various tissues 70–90 days after the last IAV infection; blood (c), spleen 
(D), and mediastinal lymph nodes (mLN) (e) of 1°M (closed bars) and 2°M CD8 T cell-bearing mice (open bars). Left—representative plots, right—summary bar 
graphs. (F) Representative plots and (g) summary bar graphs of the magnitude of NP366-specific CD8 T cell response measured in the lung vasculature (red, IV+) or 
lung parenchyma (blue, IV−) of 1°M (open bars) and 2°M CD8 T cell-bearing mice (open bars). (h) Numbers of NP366-specific lung Trm cells measured in 1°M (closed 
bars) and 2°M CD8 T cell-bearing mice (open bars). Left—representative plots, right—summary bar graphs (n = 4 mice/group). Representative of three independent 
experiments. Error bars represent mean ± SEM. Unpaired t test; *p < 0.05, **p < 0.01, ***p < 0.001.
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mice to IN challenge with a high dose (107 PFU) of recombinant 
vaccinia virus expressing full-length influenza PR8 NP (Vac-NP) 
(Figure 2A).
To formally confirm the role of CD8 T cells as the only 
mediators of pulmonary protection in this challenge model, mice 
were intraperitoneally (IP) and IN inoculated with either CD8-
depleting antibody or control rat IgG. As shown in Figure 2B, this 
regime was sufficient to deplete systemic (peripheral blood) and 
lung-residing CD8 T cells (Figure 2B). Pulmonary protection was 
assessed by measuring lung virus titers 3 days after infection—
time point experimentally determined as the peak of the viral 
load (data not shown). Both 1°M and 2°M CD8 T cell-bearing 
mice were able to control the lung Vac-NP infection (Figure 2C). 
Although we cannot completely rule out the contribution of non-
CD8 T cell-mediated cross-protective immunity against vaccinia 
infection (39), the complete loss of control of lung viral load in 
both groups of mice after depletion of CD8 T cells strongly sug-
gests that CD8 T cells are the main mediators of the observed pul-
monary protection. To our surprise, despite the large difference in 
magnitude of memory CD8 T cell responses, both 1°M and 2°M 
CD8 T cell-bearing mice displayed similar control of lung virus 
burden (Figure  2C). In both groups, we observed a reduction 
in virus titers by ~100× relative to naive controls. To rule out 
the possibility that the challenge dose of Vac-NP was not high 
enough to reveal potential differences in protection between mice 
containing 1°M and 2°M CD8 T cells, we increased the challenge 
dose by 10-fold (108 PFU) (Figure 2D). To make the experimental 
controls more stringent, we infected groups of 1°M and 2°M CD8 
T cell-bearing mice with Vac virus expressing chicken ovalbumin 
(Vac-OVA) as a non-relevant antigen (Figure 2D). Interestingly, 
in spite of the 10× increase in challenge dose of Vac-NP virus, 
similar level of pulmonary protection (>500× reduction relative 
to naive controls) was observed in both 1°M and 2°M CD8 T 
cell-bearing mice (Figure 2E). Importantly, both groups of mice 
challenged with Vac-NP showed a statistically significant decrease 
in lung virus titers relative to the infection- and age-matched 
controls challenged with Vac-OVA (Figure 2F).
Thus, despite the superior magnitude of 2°M CD8 T cell 
response observed in all the tissue compartments, the level of 
protection against localized pulmonary challenge provided by 
1°M and 2°M responses is unexpectedly similar when assessed 
70–90 days postinfection. This finding suggests that, in addition 
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to sole numbers of memory CD8 T cells, other cell intrinsic 
factors play an important role in shaping the protection against 
localized pulmonary challenge.
1°M and 2°M cD8 T cells show similar 
Phenotypic and Functional Properties
To address the possibility that secondary infection induces 
critical phenotypic and/or functional changes of memory 
CD8 T cells, this way diminishing their protective capacity, we 
performed detailed analysis of the memory CD8 T cell pool 
isolated from lungs of 1°M and 2°M mice 70–90 days post-last 
infection. Phenotypic characterization evaluating effector (Tem) 
vs central memory (Tcm) properties (KLRG-1, CD127), trafficking 
(CXCR3), response to inflammatory chemokines (CX3CR1), 
and tissue localization (CD49a) (8, 40, 41), revealed no major 
difference between memory CD8 T cells isolated from lungs (IV+ 
or IV−) of 1°M and 2°M CD8 T cell-bearing mice (Figure 3A). 
Of note, secondary IAV infection, similar to systemic infections, 
induced slower acquisition of CD62L expression (Tcm properties) 
in memory spleen- and blood-derived CD8 T cells (Figure 3B). 
At the same time, both 1°M and 2°M lung-residing CD8 T cells 
remained CD62Llo (data not shown).
Furthermore, the functional characteristics of lung-derived 
memory CD8 T cells were assessed by measuring production 
of IFNγ, TNF, and IL2 after ex vivo NP366 peptide stimulation. 
As depicted in Figure 3C, we observed no major difference in 
functionality of 1°M and 2°M cells, as they were equally able 
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(gray) performed 70–90 days post-last influenza A virus (IAV) infection. (B) Representative plots (left) and cumulative bar graphs (right) of CD62L expression 
evaluated in 1°M or 2°M NP366-specific CD8 T cells isolated from spleen (top panels) and blood (bottom panels) 70–90 days post-last IAV infection. Error bars 
represent mean ± SEM (n = 4 mice/group). Unpaired t test. **p < 0.01. Representative of 2 independent experiments. (c) Cells isolated from lungs of 1°M and 2°M 
CD8 T cell-bearing mice 70–90 days post-IAV infection were cultured ex vivo in presence of EL-4 cells coated with NP366 peptide. IV administration of CD45.2 3 min 
prior to sacrifice allowed for discrimination between lung vasculature and parenchyma. Production of IFNγ, TNF, and IL2 was assessed by intracellular staining. 
Representative plots of IFNγ (left) and TNF/IL2 staining (gated on IFNγ+; right) of ex vivo peptide-restimulated cells derived from lung vasculature (IV+) or lung 
parenchyma (IV−). (D) NP366-specific CD8 T cells were enumerated by tetramer staining performed on a separate sample from the same lung cell suspension, as 
activation of CD8 T cells induces downregulation of the TCR and does not allow for accurate enumeration. Percentage of 1°M and 2°M NP366-specific CD8 T cells 
derived from lung vasculature (IV+) or lung parenchyma (IV−) producing IFNγ as a response to ex vivo peptide restimulation (n = 4 mice/group). Representative of 
two independent experiments. Error bars represent mean ± SEM. Unpaired t test. No significant differences. (e) Cumulative data of single (black, IFNγ), double 
(gray, IFNγ + TNF), and triple (white, IFNγ + TNF + IL2) cytokine-producing CD8 T cells relative to the total IFNγ-producing CD8 T cells derived from lung vasculature 
(IV+) or lung parenchyma (IV−) of 1°M and 2°M CD8 T cell-bearing mice (n = 3 mice/group). Representative of three independent experiments. Error bars represent 
mean ± SEM. Multiple comparison two-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Statistics: IFNγ 1°M (IV−)–2°M (IV+): *****, 2°M (IV−)–2°M 
(IV+): **, 1°M (IV+)–2°M (IV+): ***, IFNγ + TNF 1°M (IV−)–2°M (IV−): *, 1°M (IV−)–2°M (IV+): ****, 2°M (IV−)–2°M (IV−): ****, and 1°M (IV+)–2°M (IV+): ****.
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lung (black line) or (B) from the lung parenchyma (blue line) on days 0–3 
post-Vac-NP infection (n = 3–5 mice/group). Representative of two 
independent experiments. Error bars represent mean ± SEM. Unpaired t test; 
*p < 0.05, **p < 0.01. (c) Ratio between numbers of NP366-specific 2°M and 
1°M CD8 T cells isolated from the whole lung (black line) or lung parenchyma 
(blue line) calculated on days 0–3 post-Vac-NP infection. (D) Representative 
NP366-specific tetramer staining of cells isolated from peripheral blood of 1°M 
and 2°M CD8 T cell-bearing mice on D0 and D3 post-Vac-NP infection. 
Representative of two independent experiments. (e) Size of NP366-specific 
CD8 T cell population measured in peripheral blood of 1°M and 2°M CD8 T 
cell-bearing mice on D3 post-Vac-NP infection relative to the baseline 
measured at D0. Representative of two independent experiments.
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to produce IFNγ, TNF, and IL2 upon peptide restimulation. 
Importantly, normalizing the numbers of IFNγ-producing CD8 
T cells to total number of NP366-specific CD8 T cells enumerated 
by tetramer staining revealed that similar percentage of antigen-
specific 1°M and 2°M CD8 T cells produce IFNγ after ex vivo 
peptide restimulation (Figure 3D). Finally, a similar fraction of 
CD8 T cells capable of producing 1, 2, or 3 cytokines upon ex vivo 
peptide restimulation was observed in both 1°M and 2°M CD8 T 
cell-bearing mice (Figure 3E). Thus, the similar level of localized 
pulmonary protection observed in mice harboring 1°M and 2°M 
CD8 T cells was not due to altered phenotype or compromised 
functionality of 2°M CD8 T cells.
Primary Memory cD8 T cells compensate 
for the initial lower numbers by higher 
Proliferation rate and superior relocation 
to the infected lung
Similar level of pulmonary protection observed in 1°M and 2°M 
CD8 T cell-bearing mice could alternatively be explained by a 
substantial increase in numbers of 1°M CD8 T cells in the lung 
during the course of the challenge infection. This would poten-
tially allow 1°M CD8 T cells to compensate for the initially low 
numbers. To directly test this hypothesis, we followed the kinetics 
of the antigen-specific CD8 T cell response upon pulmonary 
Vac-NP challenge. To this end, 1°M and 2°M CD8 T cell-bearing 
mice were exposed to IN challenge with 107 PFU of Vac-NP. Small 
group of mice was sacrificed before infection (D0) to establish 
a “baseline” NP366-specific CD8 T cell response in the lung and 
peripheral blood. Infected mice were sacrificed either on day 2 
or 3 postinfection, and a snapshot analysis of NP366-specific CD8 
T cell responses in the lung and blood was performed. On day 
of infection (D0), numbers of total or IV− NP366-specific CD8 
T cells in lungs of 2°M CD8 T cell-bearing mice were, respec-
tively, 7.5× and 11× higher compared to the lungs of 1°M CD8 
T cell-bearing mice (Figures 4A,B). Furthermore, steep increase 
in numbers of antigen-specific CD8 T cells was observed after the 
onset of the infection in both groups of mice. Interestingly, while 
numbers of antigen-specific 1°M cells continued to rise by day 
3 postinfection, numbers of 2°M cells reached a plateau by day 
2 postinfection. Due to this non-proportional expansion in the 
population size of 1°M and 2°M CD8 T cells in the lung, initial 
numerical differences were completely gone (total NP366-specific 
CD8 T cells) or substantially diminished (IV− NP366-specific 
CD8 T cells) by day 3 postinfection (Figures 4A–C). Analyses of 
NP366-specific CD8 T cells in blood revealed that while the size 
of the 2°M population seemed to be stable, the size of the 1°M 
population decreased by day 3 postinfection (Figures  4D,E), 
suggesting possible relocation of 1°M cells from the circulation 
into the lung compartment.
The major increase of 1°M cells in the infected lung could occur 
as a consequence of the substantial relocation of cells from the 
blood to the lung and/or due to a superior proliferative capacity 
of 1°M cells in the lung. To formally test this, 70–90 days after the 
last IAV infection, 1°M and 2°M CD8 T cell-bearing mice were IN 
challenged with 107 PFU Vac-NP, and half of them were injected 
IP with pertussis toxin (Ptx) before (D0) and 2 days after infection 
to block the access of circulating memory CD8 T cells into the 
infected lung (Figure 5A) (20). Mice were sacrificed 3 days post-
Vac-NP infection, and lung Vac titers and NP366-specific CD8 T 
cell responses were assessed. Proliferation of antigen-specific CD8 
T cells was assessed in both blood and lung by staining for Ki67, a 
cellular marker of proliferation (42). As shown in Figures 5B,C, 
a substantially higher proportion of 1°M relative to 2°M CD8 T 
cells had entered one of the active phases of the cell cycle (based 
on Ki67 expression) in the inflamed lung but not in the blood 
on day 3 postinfection. Additionally, Ptx treatment caused >80× 
decrease in numbers of IV− 1°M NP366-specific CD8 T cells in 
the lung, compared to <15× decrease of 2°M. At the same time, 
Ptx-induced retention of antigen-specific CD8 T cells in blood 
of 1°M CD8 T cell-bearing mice was more pronounced (16× 
increase in numbers after Ptx treatment) than in blood of 2°M 
CD8 T cell-bearing mice (4.5× increase) (Figure 5D).
Importantly, and consistent with the differential impact of Ptx 
treatment on relocation of 1°M and 2°M CD8 T cells from circu-
latory to the lung compartment, Ptx-induced block had a greater 
impact on the control of infection in mice harboring 1°M CD8 T 
cells relative to those harboring 2°M CD8 T cells. The substantial 
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FigUre 5 | superior proliferation and recruitment drive the increase 
in numbers of 1°M cD8 T cells after the onset of pulmonary 
challenge. (a) From 70 to 90 days post-influenza A virus infection, 1°M and 
2°M CD8 T cell-bearing mice together with naive control mice were exposed 
to IN challenge with 107 PFU Vac-NP. At the same day, prior to challenge, a 
group of mice was intraperitoneally injected with pertussis toxin (Ptx). Second 
dose of Ptx was administered 2 days after the Vac-NP challenge. Mice were 
sacrificed on D3, and lung virus titers were assessed by plaque assay.  
(B) Representative plots (left) and cumulative data (right) of Ki67 staining of 
NP366-specific CD8 T cells from peripheral blood of 1°M and 2°M CD8 T 
cell-bearing mice on D3 post-Vac-NP infection. (c) Representative plots (left) 
and cumulative data (right) of Ki67 staining of NP366-specific CD8 T cells from 
lung parenchyma of 1°M and 2°M CD8 T cell-bearing mice on D3 
post-Vac-NP infection (n = 4 mice/group). Representative of two independent 
experiments. Error bars represent mean ± SEM. Unpaired t test; **p < 0.01. 
(D) Numbers of NP366-specific CD8 T cells measured on D3 post-Vac-NP 
challenge in peripheral blood (left) or lung parenchyma (right) of 1°M and 2°M 
mice treated or not with Ptx (n = 4 mice/group). Representative of two 
independent experiments. Error bars represent mean ± SEM. Unpaired t test; 
**p < 0.01, ***p < 0.001, ****p < 0.0001. (e) Virus titers measured in lungs of 
1°M and 2°M CD8 T cell-bearing mice (±Ptx) 3 days after IN challenge with 
107 PFU Vac-NP (n = 7–8 mice/group). Cumulative results from two 
experiments. Error bars represent mean ± SEM. Multiple comparison 
one-way ANOVA. Only relevant statistics are depicted. **p < 0.01, 
***p < 0.001, ****p < 0.0001. N-1°M: ****, N-2°M: ****, N-1°MPtx:  
***, N-2°MPtx: ****, and 2°M-1°MPtx: ****.
8
Van Braeckel-Budimir et al. Shaping Memory CD8 T Cells
Frontiers in Immunology | www.frontiersin.org January 2017 | Volume 8 | Article 40
Ptx-induced decrease in numbers of 1°M CD8 T cells in the 
lung parenchyma was accompanied by a substantial decrease 
in protection. As depicted in Figure 5E, ~7× higher virus titers 
were measured in lungs of 1°M CD8 T cell-bearing mice treated 
with Ptx as compared to 2°M CD8 T cell-bearing mice. Taken 
together, the presented data suggest that the superior prolifera-
tive capacity of 1°M CD8 T cells in combination with increased 
recruitment into the infected lung efficiently compensates for the 
initial lower numbers of antigen-specific 1°M relative to 2°M CD8 
T cells, which eventually allows for similar control of localized 
pulmonary infection in both groups of mice.
Thus, CD8 T cell-mediated protection against localized 
pathogen infections is not exclusively determined by the magni-
tude of the response but is also influenced by multiple intrinsic 
properties (e.g., proliferation and migration to infected tissue) of 
memory CD8 T cells. History of exposure to localized infections, 
by shaping such cell properties, determines the protection against 
subsequent pathogen challenge.
DiscUssiOn
The present study describes how multiple exposures to a localized 
infection can impact the development of basic biological prop-
erties of pathogen-specific CD8 T cells and, as a consequence, 
protection against subsequent local challenge. Using well-estab-
lished influenza virus infections of mice as a model of localized 
pulmonary infections, we compared numerical and functional 
properties of the infection-induced 1°M and 2°M CD8 T cell 
pool. Our results show that secondary antigen exposure induces 
memory CD8 T cell responses of a superior magnitude relative 
to memory responses generated after a single infection. However, 
in spite of substantially lower numbers of memory CD8 T cells 
in all analyzed tissue compartments, mice bearing 1°M CD8 
T cells exhibit a similar degree of virus control after pulmonary 
challenge as 2°M CD8 T cell-bearing mice. Mechanistically, our 
data show that due to better proliferation and superior capacity 
to relocate to the site of infection, 1°M CD8 T cells substantially 
increase their numbers in the infected local tissue, allowing them 
to successfully control the viral load.
Previous studies using Listeria monocytogenes or vesicular sto-
matitis virus systemic infection models have shown that repeated 
antigen exposures have a strong impact on the magnitude of 
memory CD8 T cell responses, by defining the proliferative 
capacity, responsiveness to environmental cues, and long-term 
survival (8). Here, we show that, similar to the systemic infec-
tion, secondary localized pulmonary infection induces a memory 
CD8 T cell response of superior magnitude in blood and spleen. 
Importantly, this trend was also observed in the lung (both vas-
culature and parenchyma) and draining lymph nodes.
Previous studies comparing the functional capacity of IAV-
induced primary effector and memory CD8 T cells showed that 
although these populations exhibit similar relative cytotoxicity, 
by the virtue of larger magnitude effector responses displays 
superior killing of target cells relative to memory cells (15). In 
contrast, we show that in spite of an almost ~10× difference 
in numbers of antigen-specific CD8 T cells detected in all the 
tissues (Figure 1), and no obvious phenotypic and functional 
impairments of 2°M CD8 T cells (Figure 3), our study revealed 
a similar degree of pulmonary protection in both 1°M and 2°M 
CD8 T cell-bearing mice. This suggests that the observed pro-
tection does not depend on the sole magnitude of the memory 
CD8 T cell response but also on CD8 T cell intrinsic factors 
determined by the antigen exposure history. For example, it 
has been shown that an equal amount of 1°M and 2°M CD8 T 
cells exhibit different capacities of protection against acute vs 
chronic infection. While exhibiting better control of acute infec-
tion with LCMV Armstrong, 2°M CD8 T cells failed to control 
chronic infection with LCMV Clone 13 (10). Furthermore, 
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this study showed that a differential localization of 1°M and 
2°M CD8 T cells, shaped by exposure history, determines both 
virus control in the lymph nodes and the persistent CD8 T cell 
responses required for successful control of chronic infection. 
Additionally, it has been shown that repeated antigen stimula-
tions have a dramatic impact on the gene expression profile of 
memory CD8 T cells (8), and subsequently their basic pheno-
typic and functional properties, which can substantially impact 
the capacity to control infections (7, 8). Results of functional and 
phenotypic characterization of influenza-induced systemic 1°M 
and 2°M CD8 T cells derived from the spleen corroborate the 
basic differences described after multiple systemic antigen expo-
sures (7, 8) (data not shown). On the other hand, beside the large 
numerical differences, 1°M and 2°M CD8 T cells derived from 
the lung compartment did not exhibit any obvious phenotypic 
or functional discrepancies. Furthermore, kinetic analysis of the 
response of 1°M and 2°M CD8 T cells in the lung and blood upon 
challenge showed that by D3 post-challenge the population of 
1°M cells dramatically increases, almost to the level of the 2°M 
population. The substantially larger proportion of Ki67+ 1°M 
CD8 T cells detected in the infected lung (Figure  5) suggests 
that the superior proliferative capacity of 1°M cells contributes, 
at least partially, to this numerical increase. This finding is in 
line with the reports showing that the proliferative capacity of 
CD8 T cells decreases with every subsequent antigen encounter, 
with naive CD8 T cells exhibiting superior proliferation (7, 8). 
Administration of Ptx, which blocks the signaling through G 
protein-coupled receptors, rendering CD8 T cells incapable of 
responding to inflammatory cues, induced a significant decrease 
in the accumulation of 1°M CD8 T cells in the infected lung and 
a subsequent increase in lung virus titers. Additionally, similar 
to systemic infection, circulating 2°M CD8 T cells induced by 
localized IAV infections exhibit slower progression toward Tcm 
(CD62L expression) compared to their 1°M counterparts, sug-
gesting the possibility that difference in subset composition of 
circulating memory CD8 T cells (Tem vs Tcm) might underlie the 
differences in recruitment to the lung. Together, our data suggest 
that increased proliferation and superior capacity to relocate 
to the infected tissue allow 1°M CD8 T cells to substantially 
increase their numbers in the lung. Thus, number of available 
antigen-specific memory CD8 T cells is not the only factor 
determining the outcome of the protection against pulmonary 
challenge. Here, we present an example of how numerically 
inferior 1°M CD8 T cells can exploit differential cell properties 
to establish control of localized viral infection.
In addition to number of encounters with an infectious agent, 
biology of infection (degree of inflammation, pathogen burden, 
rate of proliferation, and cell tropism) plays an important role in 
determining the fundamental properties of memory CD8 T cells 
(43). Thus, it is likely that repeated pulmonary infections with a 
pathogen other than influenza virus (e.g., RSV and adenovirus) 
would leave a different phenotypic and functional imprint on 
the developing memory CD8 T cells, leading to diminishing 
or exacerbation of the differences observed between 1°M and 
2°M described here. Furthermore, different tissues provide a 
differential developmental environment, which will additionally 
impact the development of memory CD8 T cell properties (44). 
For example, while local infection of the skin leads to generation 
of stable, long-lived Trm population (45), lung Trm is characterized 
by rather transient nature (6). Therefore, studies utilizing various 
localized infection and challenge models will be beneficial to 
obtain more specific knowledge on the role of antigen exposure 
history on the development of pathogen-specific memory CD8 
T cell responses.
In conclusion, we have shown using an example of a localized 
pulmonary infection, how antigen exposure history can impact 
the biology of the memory CD8 T cell responses. Besides altering 
the magnitude of the response, it leaves an important imprint on 
intrinsic properties of pathogen-specific CD8 T cells, emphasized 
in differential cellular dynamics that determine the capacity to 
control lung infection.
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FigUre s1 | influenza Pa224-specific cD8 T cell responses measured in 
various tissues of 1°M and 2°M cD8 T cell-bearing mice. (a–F) Mice were 
infected as described in Figure 1. PA224-specific CD8 T cell response was 
detected by tetramer staining. (a–c) Snap shot analysis of PA224-specific CD8 
T cell response measured 70–90 days after the last influenza A virus infection; 
blood (a), spleen (B), and mediastinal lymph nodes (c) of 1°M (closed bars) and 
2°M mice (open bars). Left—representative plots, right—summary bar graphs. 
(D) Representative plots and (e) summary bar graphs of the magnitude of 
PA224-specific CD8 T cell response measured in the lung vasculature (red, IV+) 
or lung parenchyma (blue, IV−) of 1°M (closed bars) and 2°M CD8 T cell-bearing 
mice (open bars). (F) Numbers of NP366-specific lung Trm cells measured in 1°M 
(closed bars) and 2°M CD8 T cell-bearing mice (open bars). Left—representative 
plots, right—summary bar graphs (n = 4 mice/group). Representative of three 
independent experiments. Error bars represent mean ± SEM. Unpaired t test; 
*p < 0.05, **p < 0.01, ***p < 0.001.
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